Markets

Market Nav

News Details

30/05/2025 16:28

Genomic Valley Biote - Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of The SEBI (LODR) Regula

1. Considered and approved the standalone audited financial results of the company for the quarter and financial year ended 31st March 2025.\r\n2. Appointment of Mr. Yogainder Kumar Gupta (DIN: 03094998) as an 'Additional Director' in the category of Non-Executive - Independent Director on the Board of Directors of the Company w.e.f., Friday, 30th May, 2025 to hold office for a term of 5 (five) consecutive years upto May 29, 2030, subject to the approval of the shareholders in the General Meeting.\r\n3. Appointment of M/s. SBR & Co. LLP, Company Secretaries (LLP No. AAO-9057) as the Secretarial Auditors of the Company for Financial year 24-25.\r\n4. Considered Reconstitution of the Committees - Audit Committee, Stakeholders' Relationship Committee (SRC), Nomination and Remuneration Committee (NRC), Risk Management Committee as per the provisions of the Companies Act, 2013 and the SEBI (LODR) Regulations, 2015.